ARCH Venture Fund X L.P. 13D and 13G filings for Prime Medicine, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-13 4:08 pm Purchase | 2022-12-31 | 13G | Prime Medicine, Inc. PRME | ARCH Venture Fund X L.P. | 12,272,674 12.600% | 12,272,674 (New Position) | Filing |